Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Allogeneic Hematopoietic Stem Cell Transplantation for Standard Risk Inherited Metabolic Disorders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01043640
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:40.827546+00:00
Published At
2017-05-12T00:00:00+00:00
Record Updated At
2018-02-05
Results Posted At
2017-05-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Mucopolysaccharidosis", "Hurler Syndrome", "Hunter Syndrome", "Maroteaux-Lamy Syndrome", "Sly Syndrome", "Alpha Mannosidosis", "Fucosidosis", "Aspartylglucosaminuria", "Adrenoleukodystrophy (ALD)", "Krabbe Disease", "Metachromatic Leukodystrophy (MLD)", "Sphingolipidoses", "Peroxisomal Disorders"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-02-05"
protocolSection.identificationModule.nctId
"NCT01043640"
protocolSection.identificationModule.officialTitle
"Allogeneic Hematopoietic Stem Cell Transplantation for Standard Risk Inherited Metabolic Disorders"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-05-12"

Study condition terms

  • Mucopolysaccharidosis (protocolSection.conditionsModule.conditions)
  • Hurler Syndrome (protocolSection.conditionsModule.conditions)
  • Hunter Syndrome (protocolSection.conditionsModule.conditions)
  • Maroteaux-Lamy Syndrome (protocolSection.conditionsModule.conditions)
  • Sly Syndrome (protocolSection.conditionsModule.conditions)
  • Alpha Mannosidosis (protocolSection.conditionsModule.conditions)
  • Fucosidosis (protocolSection.conditionsModule.conditions)
  • Aspartylglucosaminuria (protocolSection.conditionsModule.conditions)
  • Adrenoleukodystrophy (ALD) (protocolSection.conditionsModule.conditions)
  • Krabbe Disease (protocolSection.conditionsModule.conditions)
  • Metachromatic Leukodystrophy (MLD) (protocolSection.conditionsModule.conditions)
  • Sphingolipidoses (protocolSection.conditionsModule.conditions)
  • Peroxisomal Disorders (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.